Exploration and Research on HIV/AIDS Patients’ Complement C1q Level Changes before and after Treatments


Objective: The study aimed to investigate the complement C1q test results of HIV/AIDS patients in clinical application before and after treatments. Methods: We collected HIV/AIDS patients’ serum specimens storing at -80 centigrade freezer in cryogenic refrigerator for standby. After samples quantity met the requirements of selected cases unified, complement C1q was detected by immune transmission turbidity method, and compared the differences in complement C1q of HIV/AIDS patients in test results before and after treatment. In the collection of 96 cases selected samples, concentration of complement C1q was 157.95 ± 31.46 mg/L before treatment, while after treatment, it was 147.26 ± 28.76 mg/L. Comparing the results before and after treatment, t = 2.45726, P = 0.01049, the difference was statistically significant. Concentration of complement C1q increased after treatment with 33 cases. There were 63 cases reducing. Through statistical analysis on the data from the number of reducing and increasing cases, chi-square = 18.75, P = 0.00356, the difference was statistically significant. Complement C1q detection in the treatment of patients with HIV/AIDS had an important clinical significance in the process. The analysis of the concentration changes before and after treatment was clinically significant for drug selection and monitoring disease progression and curative effects, which would be worth further researching.

Share and Cite:

Su, G. , Luo, X. , Luo, S. , Liu, Z. , Ni, Z. , Huang, W. and Liang, J. (2015) Exploration and Research on HIV/AIDS Patients’ Complement C1q Level Changes before and after Treatments. Advances in Infectious Diseases, 5, 114-117. doi: 10.4236/aid.2015.53013.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Ding, R.R. and Xing, G.Q. (2014) IgA Nephropathy Patients Complement Classic Way in Blood and Urine Activation and Its Relationship with Renal Damage. Journal of Clinical Microbiology, 31, 186-188.
[2] Liu, G., Feng, Y., Liu, X., et al. (2013) C1q Structure, Distribution, Classification and Function of Protein Family. Journal of Heredity, 35, 1072-1080.
[3] Liao, J.L., Zheng, A.P., Jiang, L., et al. (2013) Antibodies against C1q and Kidney Pathology Relations with Lupus Nephritis. Journal of Clinical and Experimental Pathology, 29, 155-158.
[4] Feng, X.B., Ke, J.J. and Rao, Y., et al. (2014) Effect of Complement C1q Expression on Hepatic Ischemia-Reperfusion Injury in Rats. J HuazhongUnivSci Technol [MedSci], 34, 403-407.
[5] Son, M., Santiago-Schwarz, F., AI-Abed, Y., et al. (2012) Clq Limits Dendritic Cell Differentiation and Activation by Engaging LAIR-1. Proceedings of the National Academy of Sciences of the United States of America, 109, E3160-E3167. http://dx.doi.org/10.1073/pnas.1212753109
[6] Xu, F.F., Bu, X.M., Li, W., et al. (2013) C1q Deposition of V-Shaped with Lupus Nephritis and the Differential Diagnosis of Primary Membranous Nephropathy Significance. Chinese Journal of Traditional Chinese and Western Medicine Combined with Kidney Disease, 14, 317-319.
[7] Hu, X.P., Liu, R.H. and Chen, J. (2014) The Test Level of C3, C4 and C1q on Judgment with Lupus Nephritis Activity of Value. Journal of Guiyang Medical College, 33, 191-193.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.